DIETER W. GUMP, M.D.; ROBERT O. FRANK, M.D.; WASHINGTON C. WINN Jr., M.D.; ROGER S. FOSTER Jr., M.D.; CLAIRE V. BROOME, M.D.; WILLIAM B. CHERRY, Ph.D.
Of nine patients with Legionnaires' disease, seven were receiving corticosteroids, and all nine had serious underlying diseases. Direct immunofluorescent examination of respiratory secretions, including sputum and transtracheal aspirates, showed the Legionnaires' disease (LD) bacterium in five of seven patients who seroconverted and in a sixth patient with a single elevated titer to the LD bacterium. All nine patients received erythromycin therapy, and five survived. Two patients showed persistence of their infection after receiving 2 weeks of erythromycin therapy, and two patients developed pulmonary abscesses. These cases of Legionnaires' disease show the occurrence of pulmonary abscesses, the possibility of relapse after giving only 2 weeks of erythromycin therapy, and the utility of direct immunofluorescence for early diagnosis.
GUMP DW, FRANK RO, WINN WC, FOSTER RS, BROOME CV, CHERRY WB. Legionnaires' Disease in Patients with Associated Serious Disease. Ann Intern Med. ;90:538–542. doi: 10.7326/0003-4819-90-4-538
Download citation file:
Published: Ann Intern Med. 1979;90(4):538-542.
Infectious Disease, Pulmonary/Critical Care.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use